EP0839045A4 - Interleukin-1 receptor-associated protein kinase and assays - Google Patents

Interleukin-1 receptor-associated protein kinase and assays

Info

Publication number
EP0839045A4
EP0839045A4 EP96919140A EP96919140A EP0839045A4 EP 0839045 A4 EP0839045 A4 EP 0839045A4 EP 96919140 A EP96919140 A EP 96919140A EP 96919140 A EP96919140 A EP 96919140A EP 0839045 A4 EP0839045 A4 EP 0839045A4
Authority
EP
European Patent Office
Prior art keywords
interleukin
assays
receptor
protein kinase
associated protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96919140A
Other languages
German (de)
French (fr)
Other versions
EP0839045A1 (en
Inventor
Zhaodan Cao
David V Goeddel
Glenn E Croston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tularik Inc
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of EP0839045A1 publication Critical patent/EP0839045A1/en
Publication of EP0839045A4 publication Critical patent/EP0839045A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP96919140A 1995-06-23 1996-06-05 Interleukin-1 receptor-associated protein kinase and assays Withdrawn EP0839045A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49400695A 1995-06-23 1995-06-23
US494006 1995-06-23
PCT/US1996/009193 WO1997000690A1 (en) 1995-06-23 1996-06-05 Interleukin-1 receptor-associated protein kinase and assays

Publications (2)

Publication Number Publication Date
EP0839045A1 EP0839045A1 (en) 1998-05-06
EP0839045A4 true EP0839045A4 (en) 1999-06-09

Family

ID=23962617

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96919140A Withdrawn EP0839045A4 (en) 1995-06-23 1996-06-05 Interleukin-1 receptor-associated protein kinase and assays

Country Status (5)

Country Link
EP (1) EP0839045A4 (en)
JP (1) JPH11509085A (en)
AU (1) AU702844B2 (en)
CA (1) CA2225450C (en)
WO (1) WO1997000690A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932425A (en) * 1997-02-18 1999-08-03 Signal Pharmaceuticals, Inc. Compositions and methods for modulating cellular NF-κB activation
US5965421A (en) 1997-11-26 1999-10-12 Human Genome Sciences, Inc. Human IRAK-2
US6262228B1 (en) * 1998-08-17 2001-07-17 Tularik Inc. IRAK3 polypeptides and methods
GB9913180D0 (en) * 1999-06-08 1999-08-04 Glaxo Group Ltd Interleukin-1 receptor associated kinases
US6965023B2 (en) 2000-11-17 2005-11-15 The Burnham Institute Death domain proteins
WO2002040680A2 (en) * 2000-11-17 2002-05-23 The Burnham Institute Death domain proteins
WO2005052132A2 (en) * 2003-11-24 2005-06-09 Exelixis, Inc Mbms as modifiers of branching morphogenesis and methods of use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MARTIN M ET AL: "Signal transduction by the IL - 1 type I receptor: evidence for the involvement of a receptor-coupled protein kinase.", BEHRING INSTITUTE MITTEILUNGEN, (1995 JUN) (96) 32-44. JOURNAL CODE: 9KI. ISSN: 0301-0457., GERMANY: Germany, Federal Republic of, XP002099831 *
OSTROWSKI J ET AL: "A serine/threonine kinase activity is closely associated with a 65-kDa phosphoprotein specifically recognized by the kappa B enhancer element.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1991 JUL 5) 266 (19) 12722-33. JOURNAL CODE: HIV. ISSN: 0021-9258., United States, XP002099832 *
See also references of WO9700690A1 *

Also Published As

Publication number Publication date
JPH11509085A (en) 1999-08-17
CA2225450C (en) 2001-05-29
WO1997000690A1 (en) 1997-01-09
AU702844B2 (en) 1999-03-04
CA2225450A1 (en) 1997-01-09
AU6176696A (en) 1997-01-22
EP0839045A1 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
EG23871A (en) Protein kinase c inhibitor
EP0852627A4 (en) Cell death protein
AU2234695A (en) Rapid assays for protein kinase activity
AU7247896A (en) Protein signature analysis
AU1448295A (en) Assay employing both protein and antibody
GB9510830D0 (en) Proteins
AU4606196A (en) Assay, receptor proteins and ligands
AU3656497A (en) Traf2-associated protein kinase and assays
EP0839045A4 (en) Interleukin-1 receptor-associated protein kinase and assays
ZA985999B (en) Protein kinases and uses thereof
AU5613498A (en) Cerebellum and embryo specific protein
AU5369396A (en) Rest protein and dna
AU6544198A (en) Protein kinase c inhibitor-like protein (ipkc-2)
AU7520396A (en) Abl-interactor protein
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
GB2303720B (en) Reject Analysis
AU1456899A (en) Human protein kinase and kinase inhibitors
AUPN024994A0 (en) Assay and peptides for use therein
GB9523497D0 (en) Cell membrane protein and application thereof
GB9519865D0 (en) Protein
HUP9801062A3 (en) A kinase anchoring protein and uses thereof
AU7080994A (en) Protein tyrosine kinase and ligands thereof
ZA987206B (en) Cycline-dependent protein kinase-activating kinase and its uses
AU8296698A (en) (kds) protein kinase molecules and uses related thereto
GB9622436D0 (en) Protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990427

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 12N 9/12 A, 6A 61K 38/00 B, 6C 07K 2/00 B, 6C 07K 4/00 B, 6C 07K 5/00 B, 6C 07K 7/00 B, 6C 07K 14/00 B, 6C 07K 16/00 B, 6C 07K 17/00 B, 6C 07H 19/00 B, 6C 07H 21/00 B

17Q First examination report despatched

Effective date: 20020227

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030812